Joel Greenblatt Arcellx, Inc. Transaction History
Gotham Asset Management, LLC
- $7.56 Billion
- Q2 2024
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Arcellx, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 9,450 shares of ACLX stock, worth $726,610. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,450
Previous 5,257
79.76%
Holding current value
$726,610
Previous $365,000
42.74%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ACLX
# of Institutions
173Shares Held
45.6MCall Options Held
53.6KPut Options Held
53.7K-
Perceptive Advisors LLC New York, NY3.89MShares$299 Million6.21% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.85MShares$296 Million8.59% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$288 Million19.51% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$270 Million0.0% of portfolio
-
Sr One Capital Management, LP2.35MShares$180 Million56.87% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.37B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...